Wrap Text
27 March 2003
Aspen Pharmacare to distribute 40 GlaxoSmithKline products
Leading local pharmaceutical manufacturer Aspen Pharmacare has entered into an
arrangement to distribute and manage 40 products belonging to GlaxoSmithKline
(GSK). Under the contract, which becomes effective 31st March 2003, Aspen will
have the responsibility for marketing, sales, pricing, distribution and customer
support of these brands for the private sector in South Africa. Manufacturing
and the intellectual property rights will remain with GSK.
Among the products involved is the former Glaxo `star", ZANTAC. Other products
are AMOXIL, ELTROXIN, FLIXONASE, IMIGRAN, SEPTRAN, WELLVONE and ZOVIRAX. (See
full list on attached page.) The contract will run for 12 years.
Commenting on the deal, Michael Spector, General Manager: Pharmaceuticals,
GlaxoSmithKline South Africa, said: "The brands involved are important products
that have been in the GSK stable for some time but which, in competing
internally for marketing resources, are just not receiving the attention they
deserve. Because of its highly respected position in the local pharmaceutical
market and the availability of its resources that can be dedicated to these
products, Aspen Pharmacare was the logical choice.
"This move allows GSK to put its full weight behind its key products in our core
therapeutic areas. It also makes good sense in terms of the current and
changing healthcare environment in South Africa."
Stephen Saad, Group CEO of Aspen Pharmacare, said: "We are delighted to be
partnering with GlaxoSmithKline on this deal. It affords Aspen the opportunity
to broaden our already strong pharmaceutical profile and to further increase our
presence in the ethicals sector of the market."
GlaxoSmithKline - one of the world"s leading research-based pharmaceutical and
healthcare companies - is committed to improving the quality of human life by
enabling people to do more, feel better and live longer.
SEE ATTACHED LIST OF PRODUCTS SUBJECT TO THIS CONTRACT.
Issued on behalf of Aspen Pharmacare, Private Bag X1593, Gallo Manor 2052 and
GlaxoSmithKline, PO Box 3388, Halfway House 1685.
For further information, please contact:
Stephen Saad, Aspen Pharmacare, Tel (031) 268 9506, 083 303 4833, or
Vicki Ehrich, Director of Corporate Affairs, GlaxoSmithKline, Tel (011) 313-
6563, 082 453 4367, or
Grace Schuurman, Grace Communications, Tel (011) 465-0309, Fax (011) 465-3956.
27 March 2003 Media-Aspen Distribution
GSK products fostered to Aspen Pharmacare
ALKERAN (melphalan hydrochloride)
AMOXIL (amoxycillin trihydrate)
AMPICLOX (ampicillin trihydrate and cloxacillin sodium)
ANGISED (glyceryl trinitrate)
AUGMENTIN (amoxycillin trihydrate and potassium clavulanate)
CUTIVATE (fluticasone propionate)
DARAPRIM (pyrimethamine)
ELTROXIN (thyroxine sodium)
FLIXONASE (fluticasone propionate)
FLOXAPEN (flucloxacillin sodium)
HALFAN (halofantrine hydrochloride)
HYCAMTIN (topotecan hydrochloride)
IMIGRAN (sumatriptan succinate)
IMURAN (azathioprine)
LANVIS (thioguanine)
LEUKERAN (chlorambucil)
MACRODANTIN (nitrofurantoin macrocrystals)
MIVACRON (mivacurium chloride)
MYLERAN (busulphan)
NARAMIG (naratriptan hydrochloride)
OTOSPORIN (polymixin B sulphate, neomycin sulphate, hydrocortisone)
PARVOLEX (n-acetylcysteine)
PREGAMAL (ferrous fumarate, folic acid)
Protamine sulphate
PURINETHOL (mercaptopurine)
QUILONUM (lithium carbonate)
RELENZA (zanamivir)
SEPTRAN (sulphamethoxazole, trimethoprim)
SOLATRAN (ketazolam)
SUPRAPEN (flucloxacillin sodium, amoxycillin trihydrate)
TRACRIUM (atacurium besylate)
TRANDATE (labetalol hydrochloride)
VENTOLIN (salbutamol sulphate)
WELLVONE (atovaquone)
ZANTAC (ranitidine hydrochloride)
ZELITREX (valaciclovir hydrochloride)
ZENTEL (albendazole)
ZINACEF (cefuroxime sodium)
ZOVIRAX (acyclovir)
ZYLOPRIM (allopurinol)
All product names in full caps are registered trademarks of the GlaxoSmithKline
Group of Companies.
Sharenet Sites 
